by YL Peng 2024 Cited by 23Febuxostat was associated with greater reduction in SUA level than allopurinol in patients with CKD. However, febuxostat and allopurinol
allopurinol users developed stage 3 of higher CKD vs. 623 patients who did not use allopurinol, indicating that use of allopurinol of 300 mg
Allopurinol lowers NT‐proBNP plasma levels and improves diastolic additional references. CKD‐FIX Study 2024 {published data only}. The CKD‐FIX
CKD-FIX and PERL are the 2 largest randomized controlled trials assessing the effect of urate lowering with allopurinol on CKD progression to date.
chronic kidney disease (CKD) and diabetes. Efficacy of Oral Allopurinol in Gout Management - Oral allopurinol is effective in lowering
Comparing Allopurinol vs Febuxostat in patients with CKD Nephpearls RheumJC
Comparing Allopurinol vs Febuxostat in patients with CKD Nephpearls RheumJC
hypertension and chronic kidney disease (CKD) Stage 3, and Febuxostat has been found to be more effective in patients with. CKD than allopurinol given at
by G Gonzalez-Martin 2024 Cited by 14RCTs for urate-lowering drugs for CKD (allopurinol) or gout [allopurinol CKD-FIXtrials of allopurinol versus placebo in CKD patients. Note
Comments